The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Lipopolysaccharide Antagonist Molecule AM-12

Discussion in 'The Gut: De Meirleir & Maes; H2S; Leaky Gut' started by JPV, Aug 19, 2015.

  1. JPV

    JPV ɹǝqɯǝɯ ɹoıuǝs

    Messages:
    858
    Likes:
    1,097
    Has anybody heard of this before?
     
    rosie26 likes this.
  2. msf

    msf Senior Member

    Messages:
    3,326
    Likes:
    4,654
    Looks promising, at least for those with leaky gut. I don´t know if you would want to do this with a pathogenic bacteria though, I guess it would depend on how virulent it was.
     
  3. alex3619

    alex3619 Senior Member

    Messages:
    13,043
    Likes:
    37,014
    Logan, Queensland, Australia
    LPS is a super antigen. It can drive someone with a LPS based bacterial infection into septic shock. Blocking LPS will not stop the immune system from fighting a bacterial infection. It will just slow down the severity and speed of the immune response. In anyone with a severe immune response this would be a good thing.

    I would like to see human clinical trials if the research keeps showing results.
     
    rosie26 likes this.
  4. msf

    msf Senior Member

    Messages:
    3,326
    Likes:
    4,654
    I was referring to its potential use in ME, rather than in sepsis.

    KDM has talked about the potential efficacy of such a approach in Lyme.
     

See more popular forum discussions.

Share This Page